What is NDC 73554-3111?

73554-3111 is the product NDC for Zynteglo (betibeglogene autotemcel), Betibeglogene autotemcel 20000000 1/1 suspension, listed with the FDA by Genetix Biotherapeutics Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Zynteglo (Betibeglogene autotemcel).

Genetix Biotherapeutics Inc., NDC labeler code 73554. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zynteglo?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Zynteglo NDC 73554-3111 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)73554-3111Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73554-3111Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73554-3111-1	73554311101	1 SUSPENSION in 1 BAG (73554-3111-1)Marketed from Aug 17, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zynteglo
Generic name (nonproprietary): betibeglogene autotemcel
Active ingredients: Betibeglogene autotemcel — 20000000 1/1
Dosage form: Suspension
Route: Intravenous
Labeler: Genetix Biotherapeutics Inc.NDC labeler code 73554
Product type: Cellular therapy
Marketing category: BLA — Biologics License ApplicationApplication BLA 125717
Marketing start: Aug 17, 2022
Listing expires: Dec 31, 2027
Identifiers: Product ID 73554-3111_ad3b5513-b7ff-492d-ad78-ea5a4bd44510SPL ID ad3b5513-b7ff-492d-ad78-ea5a4bd44510SPL set ID 86931613-c262-47f5-8202-bc31fa69ad3dRxCUI 2610435, 2610436UNII MEE8487RTPUPC 0373554311114

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N473554311101 followed by a unit qualifier and the quantity

Package 73554-3111-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 21, 2026.

Indications (excerpt from the label)

ZYNTEGLO is indicated for the treatment of adult and pediatric patients with β-thalassemia who require regular red blood cell (RBC) transfusions. ZYNTEGLO is an autologous hematopoietic stem cell-based gene therapy indicated for the treatment of adult and pediatric patients with β-thalassemia who require regular red blood cell (RBC) transfusions. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73554-3111

What is NDC 73554-3111?: 73554-3111 is the product NDC for Zynteglo (betibeglogene autotemcel), Betibeglogene autotemcel 20000000 1/1 suspension, listed with the FDA by Genetix Biotherapeutics Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Zynteglo (Betibeglogene autotemcel).
What is the active ingredient?: Betibeglogene autotemcel.
Who is the labeler?: Genetix Biotherapeutics Inc., NDC labeler code 73554. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zynteglo?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Zynteglo (Betibeglogene autotemcel) NDC 73554-3111